ArticleNPJ precision oncology2024

A new TROP2-targeting antibody-drug conjugate shows potent antitumor efficacy in breast and lung cancers.

Dan-Dan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.